In support of its pro-apoptotic role in vivo, ANT1 transfection in breast adenocarcinoma cells in a nude mouse model induced apoptosis, increased Bax expression, and finally stimulated tumor regression, validating the hypothesis that ANT1 could be a potent therapeutic target for the treatment of cancer [56]. This evidence concerns the gene SLC25A4 and cancer.